Sophisticated blood tests offer a less invasive way to characterize cancers, guide treatment and catch recurrences sooner, but tissue biopsies remain the gold standard.

by Kendall K. Morgan

Forward Look

Whether lung cancer patients receive PET scans depends on race, according to a study.

by Ashley P. Taylor

Healthy Habits

Eating tree nuts may decrease cancer risk, especially for cancers of the digestive system.

by Tara Santora

Forward Look

Hypofractionation may allow patients to finish radiation treatment sooner.

by Stephen Ornes

Breast cancer patients' symptoms after radiation therapy may go underrecognized, especially if these patients are Black or younger in age.

by Marci A. Landsmann

A study indicates that some breast cancer patients who receive mastectomy and reconstruction may be at risk of persistent drug use following surgery.

by Marcus A. Banks

Doctors at cancer centers in states with record COVID-19 hospitalization rates reflect on how lessons from early in the pandemic are helping them care for patients during the current surge.

by Ashley P. Taylor

Socioeconomic factors and racism can lead to poorer health outcomes for Black Americans. Genetics may also be a factor behind increased mortality rates.

by Marci A. Landsmann

A study shows that a blood test for gastrointestinal tumor mutations gave results in a third of the time needed for solid tissue testing. Patients who received the blood test were more likely to enroll in clinical trials.

by Emma Yasinski

The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it's not clear the biomarker is valid across all cancer types.

by Anna Azvolinsky